|
|
|
|
LEADER |
00863nam a2200301 i 4500 |
001 |
NSK01000358211 |
003 |
HR-ZaNSK |
008 |
920512s1991 xxkad 001 0 eng |
020 |
|
|
|a 0412361108
|
035 |
|
|
|9 (HR-ZaNSK)358627
|
035 |
|
|
|9 (HR-ZaNSK)920512060
|
035 |
|
|
|a (HR-ZaNSK)000358211
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|
044 |
|
|
|a uk
|
080 |
|
|
|a 612.815.01:615
|
080 |
|
|
|a 615.21:612.8
|
100 |
1 |
|
|a Kruk, Zygmunt L.
|
245 |
1 |
0 |
|a Neurotransmitters and drugs /
|c Zygmunt L. Kruk, Christopher J. Pycock.
|
250 |
|
|
|a 3rd ed
|
260 |
|
|
|a London [etc.] :
|b Chapman & Hall,
|c 1991.
|
300 |
|
|
|a VII, 204 str. :
|b ilustr. ;
|c 24 cm.
|
504 |
|
|
|a Bibliografija uz svako poglavlje
|
504 |
|
|
|a Kazalo
|
700 |
1 |
|
|a Pycock, Christopher J.
|
852 |
4 |
|
|j 644.412
|
876 |
|
|
|e K
|a 877/92
|
886 |
0 |
|
|2 unimarc
|b 00715nam0 2200253 450
|